| BMI | Body Mass Index |
| COC | Combined oral contraceptives |
| d | per day |
| FDA | Food and Drug Administration |
| HOMA-IR | Homeostasis Model Assessment-Insulin Resistance |
| LIRA | Liraglutid |
| MEN | Multiple Endocrine Neoplasia |
| MET | Metformin |
| Mo | months |
| MYO | Myoinositol |
| NICHD | National Institute of Child Health and Human Development |
| NIH | National Institute of Health |
| PCOS | Polycystic Ovary Syndrome |
| PPAR | Peroxisome Proliferator activated receptor |
| ROS | Rosiglitazone |
| SDS | standard deviation score |
| SPIOMET | Spironolactone, pioglitazone, metformin |
| SPIRO | Spironolactone |
| we | weeks |